Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2016

Open Access 01-12-2015 | Research article

The neuritogenic and neuroprotective potential of senegenin against Aβ-induced neurotoxicity in PC 12 cells

Authors: Robert Jesky, Hailong Chen

Published in: BMC Complementary Medicine and Therapies | Issue 1/2016

Login to get access

Abstract

Background

Improved therapeutics aimed at ameliorating the devastating effects of neurodegenerative diseases, such as Alzheimer’s disease (AD), are pertinent to help attenuate their growing prevalence worldwide. One promising avenue for such therapeutics lies in botanical medicines that have been efficaciously employed in the likes of traditional medicine doctrines for millennium. Integral to this approach is the necessity of neuritogenesis and/or neuroprotection to counterbalance the deleterious effects of amyloid-β (Aβ) proteins. Senegenin, a principle saponin of Polygala tenuifolia Willd., which has empirically shown to improve cognition and intelligence, was chosen to evaluate its cytoprotective potential and possible neuritogenic and neuroprotective effects.

Methods

The purpose of the present study was then to analyze morphological changes in neurite development and altered protein expression of two proteins requisite to neuritogenesis, growth associated protein 43 (Gap-43) and microtubule-associated protein 2 (MAP2) in PC 12 cells. Neuritogenic analysis was conducted with immunofluorescence after incubation with Aβ (25–35) peptide, and to deduce information on cell viability and mitochondrial functionality MTT (3,(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide) was employed.

Results

This study found that cells pre-incubated with senegenin for 24 h (40 μg and 20 μg/ml) before introducing Aβ attenuated Aβ-cytotoxicity, and significantly increased cell viability by 23 % and 34 % (P < 0.001), respectively. In neurite outgrowth experiments, Aβ was compared to NGF positive control and senegenin treated groups which showed a drastic decrease in the quantity, average length and maximum length of neurites (P < 0.001). At concentrations of 1 μg/ml (P < 0.01) and 5 μg/ml (P < 0.05) senegenin triggered neuritogenesis with significant increases in total neurite number, average length and maximum length. This was additionally shown through the augmented expression of MAP2 and Gap-43.

Conclusions

These results suggest that senegenin possesses cytoprotective properties, can moderate neurite outgrowth and augment MAP2 and Gap-43, thus suggesting a potential therapeutic value for Polygala tenuifolia in neurodegenerative disorders.
Literature
1.
Taylor JP, Hardy T, Fischbeck KH. Toxic Proteins in Neurodegenerative Disease. Science. 2002;296(5575):1991–5.CrossRefPubMed
2.
Selkoe DJ. Alzheimer’s Disease: genes, proteins, and therapy. Physiol Rev. 2001;81(2):741–66.PubMed
3.
Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297:353–6.CrossRefPubMed
4.
Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, et al. Diffusible, nonfibrillar ligands derived from Abeta1–42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A. 1998;95(11):6448–53.CrossRefPubMedPubMedCentral
5.
6.
Glabe CG. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging. 2006;27(4):570–5.CrossRefPubMed
7.
Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, et al. Synaptic Targeting by Alzheimer’s-Related Amyloid-β Oligomers. J Neurosci. 2004;24(45):10191–200.CrossRefPubMed
8.
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Alzheimer’s Disease International: Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366(9503):2112–7.CrossRefPubMedPubMedCentral
9.
Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells with respond to nerve growth factor. Proc Natl Acad Sci U S A. 1976;73(7):2424–8.CrossRefPubMedPubMedCentral
10.
Pollock JD, Krempin M, Rudy B. Differential effects of NGF, FGF, EGF, cAMP, and dexamethasone on neurite outgrowth and sodium channel expression in PC12 cells. J Neurosci. 1990;10(8):2626–37.PubMed
11.
Brugg B, Matus A. PC 12 cells express juvenile microtubule-associated proteins during nerve growth factor-induced neurite growth. J Cell Biol. 1988;107(2):643–50.CrossRefPubMed
12.
Karns LR, Ng SC, Freeman JA, Fishman MC. Cloning of complementary DNA for GAP-43, a neuronal growth-related protein. Science. 1987;236(4801):597–600.CrossRefPubMed
13.
Van Hooff CO, De Graan PN, Oestreicher AB, Gispen WH. B-50 phosphorylation and polyphosphoinositide metabolism in nerve growth cone membranes. J Neurosci. 1988;8(5):1789–95.PubMed
14.
Meiri KF, Pfenninger KH, Willard MB. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp 46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc Natl Acad Sci U S A. 1986;83(10):3537–41.CrossRefPubMedPubMedCentral
15.
Costello B, Meymandi A, Freeman JA. Factors Influencing GAP-43 Gene Expression in PC1 2 Pheochromocytoma Cells. J Neurosci. 1990;10(4):1396–406.
16.
17.
Seeds NW, Gilman AG, Amano T, Nirenberg MW. Regulation of axon formation by clonal lines of neural tumor. Proc Natl Acad Sci U S A. 1970;66(1):160–7.CrossRefPubMedPubMedCentral
18.
Sánchez C, Díaz-Nido J, Avila J. Variations in in viva phosphorylation at the proline-rich domain of the microtubule-associated protein 2 (MAP2) during rat brain development. J Biochem. 1995;306:481–7.CrossRef
19.
Sánchez C, Díaz-Nido J, Avila J. Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog Neurobiol. 2000;61(2):133–68.CrossRefPubMed
20.
Pang L, Sawada T, Decker SJ, Saltiel AR. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem. 1995;270:13585–8.CrossRefPubMed
21.
Cáceres A, Banker GA, Binder L. Immunocytochemical Localization of Tubulin and Microtubule-Associated Protein 2 During the Development of Hippocampal Neurons in Culture. J Neurosci. 1986;6(3):714–22.PubMed
22.
Jahn R, Schiebler W, Ouimet C, Greengard P. A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc Natl Acad Sci U S A. 1985;82(12):4137–41.CrossRefPubMedPubMedCentral
23.
Nieto-Sampedro M, Nieto-Díaz M. Neural Plasticity: changes with age. J Neural Transm. 2005;112(1):3–27.CrossRefPubMed
24.
Burke SN, Barnes CA. Neural plasticity in the ageing brain. Nature Rev Neurosci. 2006;7:30–40.CrossRef
25.
Kempermann G, Kuhn HG, Gage FH. More hippocampal neurons in adult mice living in an enriched environment. Nature. 1997;386(6624):493–5.CrossRefPubMed
26.
Eriksson PS, Perfilieva E, Björk-Eriksson T, Alborn AM, Nordborg C, Peterson DA, et al. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4(11):1313–7.CrossRefPubMed
27.
Kromer LF. Nerve growth factor treatment after brain injury prevents neuronal death. Science. 1987;235(4785):214–6.CrossRefPubMed
28.
Prakash N, Cohen-Cory S, Penschuck S, Frostig RD. Basal forebrain cholinergic system is involved in rapid nerve growth factor (NGF)-induced plasticity in the barrel cortex of adult rats. J Neurophysiol. 2004;91(1):424–37.CrossRefPubMed
29.
Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol. 2001;11(3):272–80.CrossRefPubMed
30.
McAllister AK, Katz LC, Lo DC. Neurotrophins and synaptic plasticity. Annu Rev Neurosci. 1999;22:295–318.CrossRefPubMed
31.
Friden PM, Walus LR, Watson P, Doctrow SR, Kozarich JW, Backman C, et al. Blood–brain barrier penetration and in vivo activity of an NGF conjugate. Science. 1993;259(5093):373–7.CrossRefPubMed
32.
Bäckman C, Rose GM, Hoffer BJ, Henry MA, Bartus RT, Friden P, et al. Systemic administration of a Nerve Growth Factor Conjugate Reverses Age-Related Cognitive Dysfunction and Prevents Cholinergic Neuron Atrophy. J Neurosci. 1996;16(17):5437–42.PubMed
33.
Yamada K, Nitta A, Hasegawa T, Fuji K, Hiramatsu M, Kameyama T, et al. Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer’s disease. Behav Brain Res. 1997;83(1–2):117–22.CrossRefPubMed
34.
35.
Liu WB, Liu WZ. Disciplinarian investigation of Chinese complex prescription with promoting intelligence in past dynasties. Jiangxi J Traditional Chin Med. 2005;36:62–3.
36.
Park CH, Choi SH, Koo JW, Seo JH, Kim HS, Jeong SJ, et al. Novel cognitive improving and neuroprotective activities of Polygala tenuifolia Willdenow extract, BT-11. J Neurosci Res. 2002;70(3):484–92.CrossRefPubMed
37.
Karakida F, Ikeya Y, Tsunakawa M, Yamaguchi T, Ikarashi Y, Takeda S, et al. Cerebral Protective and Cognition-Improving Effects of Sinapic Acid in Rodents. Biol Pharm Bull. 2007;30(3):514–9.CrossRefPubMed
38.
Jia H, Jiang Y, Ruan Y, Zhang Y, Ma X, Zhang J, et al. Tenuigenin treatment decreases secretion of the Alzheimer’s disease amyloid-β protein in cultured cells. Neurosci Lett. 2004;367(1):123–8.CrossRefPubMed
39.
Lv J, Jia H, Jiang Y, Ruan Y, Liu Z, Yue W, et al. Tenuifolin, an extract derived from tenuigenin, inhibits amyloid-β secretion in vitro. Acta Physiol (Oxf). 2009;196(4):419–25.CrossRef
40.
Zhang H, Han T, Zhang L, Yu CH, Wan DG, Rahman K, et al. Effects of tenuifolin extracted from radix polygalae on learning and memory: A behavioral and biochemical study on aged and amnesic mice. Phytomedicine. 2008;15(8):587–94.CrossRefPubMed
41.
Yabe T, Tuchida H, Kiyohara H, Takeda T, Yamada H. Induction of NGF synthesis in astrocytes by onjisaponins of Polygala tenuifolia, constituents of kampo (Japanese herbal) medicine Ninjin-yoei-to. Phytomedicine. 2003;10(2–3):106–14.CrossRefPubMed
42.
Park HJ, Lee K, Heo H, Lee M, Kim JW, Whang WW, et al. Effects of Polygala tenuifolia Root Extract on Proliferation of Neural Stem Cells in the Hippocampal CA1 Region. Phytother Res. 2008;22(10):1324–9.CrossRefPubMed
43.
Ban JY, Cho SO, Koh SB, Song KS, Bae K, Seong YH. Protection of amyloid beta protein (25–35)-induced neurotoxicity by methanol extract of Smilacis chinae rhizome in cultured rat cortical neurons. J Ethnopharmacol. 2006;106(2):230–7.CrossRefPubMed
44.
Qian YH, Han H, Hu XD, Shi LL. Protective effect of ginsenoside Rb1 on β-amyloid protein (1–42)-induced neurotoxicity in cortical neurons. Neurol Res. 2008;31:663–7.CrossRef
45.
Sano M, Grossman H, Van Dyk K. Preventing Alzheimer’s disease separating fact from fiction. CNS Drugs. 2008;22:887–902.CrossRefPubMed
46.
Tohda C, Matsumoto N, Zou K, Meselhy MR, Komatsu K. Abeta(25–35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins. Neuropsychopharmacology. 2004;29(5):860–8.CrossRefPubMed
47.
Kim JH, Ha HC, Lee MS, Kang JI, Kim HS, Lee SY, et al. Effect of Tremella fuciformis on the Neurite Outgrowth of PC12h Cells and the Improvement of Memory in Rats. Biol Pharm Bull. 2007;30(4):708–14.CrossRefPubMed
48.
Cui L, Locatelli L, Xie MY, Sommadossi JP. Effect of Nucleoside Analogs on Neurite Regeneration and Mitochondrial DNA Synthesis in PC-12 Cells. J Pharmacol Exp Ther. 1997;280(3):1228–34.PubMed
49.
50.
Tohda C, Tamura T, Matsuyama S, Komatsu K. Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus. Br J Pharmacol. 2006;149(5):532–41.CrossRefPubMedPubMedCentral
51.
Murphy AN, Fiskum G, Beal MF. Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J Cereb Blood Flow Metab. 1999;19(3):231–45.CrossRefPubMed
52.
Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, et al. A model for 3-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease. Proc Natl Acad Sci U S A. 1994;91(8):3270–4.CrossRefPubMedPubMedCentral
53.
Shearman MS, Ragan CI, Iversen LL. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of 1-amyloid-mediated cell death. Proc Natl Acad Sci U S A. 1994;91(4):1470–4.CrossRefPubMedPubMedCentral
54.
Hughes E, Burke RM, Doig AJ. Inhibition of Toxicity in the β-Amyloid Peptide Fragment β-(25–35) Using N-Methylated Derivatives: a general strategy to prevent amyloid formation. J Biol Chem. 2000;275(33):25109–15.CrossRefPubMed
55.
Nishida H, Kushida M, Nakajima Y, Ogawa Y, Tatewaki N, Sato S, et al. Amyloid-β-Induced Cytotoxicity of PC-12 Cell Was Attenuated by Shengmai-san Through Redox Regulation and Outgrowth Induction. J Pharmacol Sci. 2007;104(1):73–81.CrossRefPubMed
56.
Troy CM, Rabacchi SA, Friedman WJ, Frappier TF, Brown K, Shelanski ML. Caspase-2 mediates neuronal cell death induced by β-Amyloid. J Neurosci. 2000;20(4):1386–92.PubMed
57.
Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K, et al. Amyloid-β induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ. 2005;12(1):19–24.CrossRefPubMed
58.
Hsu MJ, Hsu CY, Chen BC, Chen MC, Ou G, Lin CH. Apoptosis signal regulating kinase 1 in amyloid beta peptide-induced cerebral endothelial cell apoptosis. J Neurosci. 2007;27:5719–29.CrossRefPubMed
59.
Morishima Y, Gotoh Y, Zieg J, Barrett T, Takano H, Flavell R, et al. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci. 2001;21(19):7551–60.PubMed
60.
Shea TB, Perrone-Bizzozero NI, Beermann ML, Benowitz LI. Phospholipid-mediated delivery of anti-GAP-43 antibodies into neuroblastoma cells prevents neuritogenesis. J Neurosci. 1991;11(6):1685–90.PubMed
61.
Meiri KF, Willard M, Johnson MI. Distribution and Phosphorylation of the Growth-Associated Protein GAP-43 in Regenerating Sympathetic Neurons in Culture. J Neurosci. 1988;8(7):2571–81.PubMed
62.
Aloyo VJ, Zwiers H, Gispen WH. Phosphorylation of B-50 protein by calcium-activated, phospholipid-dependent protein kinase and B-50 protein kinase. J Neurochem. 1983;41(3):649–53.CrossRefPubMed
63.
Shen Y, Mani S, Donovan SL, Schwob JE, Meiri KF. Growth-Associated Protein-43 is required for commissural axon guidance in the developing vertebrate nervous system. J Neurosci. 2002;22(1):239–47.PubMed
64.
Hsu L, Jeng AY, Chen KY. Induction of neurite outgrowth from chick embryonic ganglia explants by activators of protein kinase C. Neurosci Lett. 1989;99(3):257–62.CrossRefPubMed
65.
Yankner BA, Benowitz LI, Villa-Komaroff L, Neve RL. Transfection of PC12 cells with the human GAP-43 gene: effects on neurite outgrowth and regeneration. Brain Res Mol Brain Res. 1990;7(1):39–44.CrossRefPubMed
66.
Quinlan EM, Halpain S. Emergence of activity-dependent, bidirectional control of microtubule-associated protein MAP2 phosphorylation during postnatal development. J Neurosci. 1996;16(23):7627–37.PubMed
67.
Diez-Guerra FJ, Avila J. An increase in phosphorylation of microtubule-associated protein 2 accompanies dendrite extension during the differentiation of cultured hippocampal neurons. Eur J Biochem. 1995;227(1–2):68–77.CrossRefPubMed
68.
Caceres A, Binder LI, Payne MR, Bender P, Rebhun L, Steward O. Different sub cellular localization of tubulin and the microtubule associated protein MAP2 in brain tissue as revealed by immunocytochemistry with monoclonal hybridoma antibodies. J Neurosci. 1984;4:394–410.PubMed
69.
Brugg B, Matus A. Phosphorylation Determines the Binding of Microtubule-associated Protein 2 (MAP2) to Microtubules in Living Cells. J Cell Biol. 1991;114(4):735–43.CrossRefPubMed
70.
Ainsztein AM, Purich DL. Stimulation of Tubulin Polymerization by MAP-2. J Biol Chem. 1994;269(45):28465–71.PubMed
71.
Miyasaka T, Chao MV, Sherline P, Saltiel AR. Nerve growth factor stimulates a protein kinase in PC-12 cells that phosphorylates microtubule-associated protein-2. J Biol Chem. 1990;265(8):4730–5.PubMed
Metadata
Title
The neuritogenic and neuroprotective potential of senegenin against Aβ-induced neurotoxicity in PC 12 cells
Authors
Robert Jesky
Hailong Chen
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2016
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-016-1006-3

Other articles of this Issue 1/2016

BMC Complementary Medicine and Therapies 1/2016 Go to the issue

Research article

Antiproliferation of Cryptocarya concinna-derived cryptocaryone against oral cancer cells involving apoptosis, oxidative stress, and DNA damage

Research article

Glucosamine sulfate suppresses the expression of matrix metalloproteinase-3 in osteosarcoma cells in vitro

Research article

Antidiabetic activity of the ethyl acetate fraction of Ficus lutea (Moraceae) leaf extract: comparison of an in vitro assay with an in vivo obese mouse model

Research article

Protective effects of hydroponic Teucrium polium on hippocampal neurodegeneration in ovariectomized rats

Research article

Chemical composition, in vitro antioxidant and anti-inflammatory properties of essential oils of four dietary and medicinal plants from Cameroon

Research article

In vivo sedative activity of methanolic extract of Stericulia villosa Roxb. leaves